UPDATE 3-Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder

(Adds price and availabilty in paragraph 7) By Sneha S K and Padmanabhan Ananthan Aug 19 (Reuters) – Ultragenyx Pharmaceutical said on Wednesday that its gene therapy became the first to receive the

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)